Yokoyama, K.; Fukuda, H.; Yamauchi, R.; Higashi, M.; Miyayama, T.; Higashi, T.; Uchida, Y.; Shibata, K.; Tsuchiya, N.; Fukunaga, A.;
et al. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina 2022, 58, 1276.
https://doi.org/10.3390/medicina58091276
AMA Style
Yokoyama K, Fukuda H, Yamauchi R, Higashi M, Miyayama T, Higashi T, Uchida Y, Shibata K, Tsuchiya N, Fukunaga A,
et al. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina. 2022; 58(9):1276.
https://doi.org/10.3390/medicina58091276
Chicago/Turabian Style
Yokoyama, Keiji, Hiromi Fukuda, Ryo Yamauchi, Masashi Higashi, Takashi Miyayama, Tomotaka Higashi, Yotaro Uchida, Kumiko Shibata, Naoaki Tsuchiya, Atsushi Fukunaga,
and et al. 2022. "Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites" Medicina 58, no. 9: 1276.
https://doi.org/10.3390/medicina58091276
APA Style
Yokoyama, K., Fukuda, H., Yamauchi, R., Higashi, M., Miyayama, T., Higashi, T., Uchida, Y., Shibata, K., Tsuchiya, N., Fukunaga, A., Umeda, K., Takata, K., Tanaka, T., Shakado, S., Sakisaka, S., & Hirai, F.
(2022). Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina, 58(9), 1276.
https://doi.org/10.3390/medicina58091276
